Reported 9 days ago
Abbott Laboratories (ABT) has emerged as one of the most profitable dividend stocks with a net profit margin of nearly 32%. In a market marked by instability, dividend stocks are regaining popularity, with Abbott showing consistent growth and a 53-year streak of dividend increases. Recently, the company reported $11 billion in revenue for Q4 2024, despite slightly missing Wall Street expectations. As interest in stable dividend stocks rises due to economic challenges, Abbott's financial health and commitment to dividends make it a key player in the dividend investing landscape.
Source: YAHOO